MedPath
NMPA Approval

Teprotumumab N01 Injection

国药准字S20250013

March 11, 2025

Drug Information

替妥尤单抗N01注射液

信必敏

注射剂

500 mg(10 ml)/瓶

生物制品

March 11, 2025

Company Information

Applicant Company

苏州工业园区东平街168号

Manufacturing Company

苏州工业园区东平街168号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

替妥尤单抗N01注射液 - NMPA 批准文号 | MedPath